↑ Rising
Health
🔮 holds ✗
Drug Topics
Coverage by Drug Topics as tracked by Newsylist.
10trends covered
0broke first
10articles tracked
◼ Archived
Business
🔮 holds ✗
FDA approves new use of popular diabetes drug
◼ Archived
Health
🔮 holds ✗
Trump administration quietly signals possible changes coming to childhood vaccine schedule
◼ Archived
Business
🔮 holds ✓
Eli Lilly delays FDA filing for next-generation weight-loss drug retatrutide
Eli Lilly is planning a Q1 2027 FDA application for retatrutide following new data on weight loss and A1C improvements.
◼ Archived
Health
🔮 holds ✓
24 GLP-1 Users Reveal The Good, The Bad, And The Shocking Side Effects
GLP-1 weight-loss medications are seeing a massive surge in adoption, sparking debates over side effects and social disclosure.
◼ Archived
Health
🔮 fades ✓
She Used Weight-Loss Drugs From a Telehealth Company, Then a GLP-1 Overdose Sent Her to the ER
5 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.
◼ Archived
Health
🔮 holds ✓
The pitfalls of using social media and AI for health decisions, according to a doctor
5 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.
◼ Archived
Health
🔮 holds ✓
West Nile is spreading faster than it has in 20 years. Here’s how to keep yourself safe
10 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
‘World’s most contagious disease’ on track for highest US cases in 35 years
◼ Archived
Health
🔮 holds ✗
Eli Lilly and Company (LLY) CEO on How GLP-1s Will Reshape America
Eli Lilly's CEO outlines the transformative potential of GLP-1s as new oral weight-loss medications enter development.